near-significantp<0.05
However, because a near-significant effect was observed in the latter case, we report that a significant difference (post-hoc Conover test, p<0.05) was present between patients on DMARD therapy (median 3, IQR 2-6) and patients receiving glucocorticoids (median 5, IQR 3-7) and combined NSAID + glucocorticoid therapy (median 5, IQR 3.3-7).